Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-25

Clinical Trial Update: Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris [Phase 4]

View source ↗

Summary

Phase 4 trial update on Wen Xin Granules for unstable angina within coronary heart disease, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Wen Xin Granules

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Coronary Heart Disease, Unstable Angina | Phase 4 | Status: UNKNOWN